Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
50.33
+1.66 (3.41%)
At close: Jul 19, 2024, 4:00 PM
50.28
-0.05 (-0.10%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $1.50 billion as of July 22, 2024. Its market cap has increased by 359.00% in one year.
Market Cap
1.50B
Enterprise Value
1.41B
1-Year Change
359.00%
Ranking
Category
Stock Price
$50.33
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $1.50B, an increase of 937.24%. That is a compound annual growth rate of 186.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.47B | 28.79% |
| Dec 29, 2023 | 1.14B | 56.81% |
| Dec 30, 2022 | 726.40M | 402.45% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.55B |
| Schrödinger | 1.55B |
| Alphatec Holdings | 1.55B |
| Teladoc Health | 1.54B |
| Kiniksa Pharmaceuticals | 1.51B |
| Spyre Therapeutics | 1.50B |
| InMode | 1.50B |
| Tilray Brands | 1.48B |